Journal Report

Kidney Cancer

Download PDF
Journal Information
Journal Title
Kidney Cancer
Publisher
SAGE Publications Ltd
ISSN
2468-4562
E-ISSN
2468-4570
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓
2025 ✓
2024 ✓
2023 ✓
2021/2022
2020
2019
2018
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Analysis of the global, regional, and national burden of kidney cancer and projections until 2036
Xiaotong Wang, Jing Shan, Li Ma
2026-8-6
DOI: 10.1177/24684562261474671
Real-World effectiveness of second-line cabozantinib in metastatic renal cell carcinoma in the era of immunotherapy combinations: Results from the international metastatic renal cell carcinoma database consortium (IMDC)
Martin Zarba, Dylan E. O’Sullivan, Razane El Hajj Chehade et al.
2026-3-17
DOI: 10.1177/24684562251411428
Pragmatic trials in renal cell carcinoma
Zachary Creech, Daniel J. George, Matthew Labriola
2025-7 Vol. 9 Pages 45-54
DOI: 10.1177/24684562251408293
Role of immune check point inhibitor rechallenge in metastatic renal cell carcinoma
Hatice Bölek, Satı Coşkun Yazgan, Yüksel Ürün et al.
2025-7 Vol. 9 Pages 20-23
DOI: 10.1177/24684562251357795
Clinical trials corner: Take a BiTE out of kidney cancer
2025-7 Vol. 9 Pages 35-36
DOI: 10.1177/24684562251357793
Spatial clustering of immunosuppressive macrophages in papillary renal cell carcinoma
Mitchell T Hayes, Jose Laborde, Alex Soupir et al.
2025-7 Vol. 9 Pages 24-34
DOI: 10.1177/24684562251358595
Assessing genetic and urologic providers on renal screening recommendations for individuals with a familial renal cancer risk
Lindsey Byrne, Peyton Nunley, Kristen Pauley et al.
2025-7 Vol. 9 Pages 37-44
DOI: 10.1177/24684562251391575
Surgical approaches following durable responses to immunotherapy
Brittney H Cotta, Pavlos Msaouel, Jose A Karam
2025-5-19 Vol. 9
DOI: 10.1177/24684562251332757
Durable responses to immune checkpoint inhibitor-based regimens for metastatic clear cell renal cell carcinoma stratified by IMDC risk groups: A pooled analysis of four randomized phase 3 trials
Albert Jang, Jeffrey Y. Zhong, Hamsa L.S. Kumar et al.
2025-1 Vol. 9
DOI: 10.1177/24684570241311419
Introduction to updates in kidney tumor classification, morphology, and molecular alterations in <i>Kidney Cancer</i>
Michelle S Hirsch
2025-1 Vol. 9 Issue 1_suppl Pages 1-3
DOI: 10.1177/24684562251340806
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 10, 2026 18:27